A Phase I/II Study of Polymerized Bovine Hemoglobin in Adult Patients with Sickle Cell Disease not in Crisis at the Time of Study

Journal of Investigative Medicine

Volumn 45, Issue 5, 1997, Pages 258-264

  Gonzalez, Pablo ^a   Hackney, Anthony C ^a   Jones, Susan ^a   Strayhorn, Dell ^a   Hoffman, Elaine Borland ^a   Hughes, George ^a   Jacobs, Edward E ^a   Orringer, Eugene P ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Bovine hemoglobin; Oxygen carrier; Sickle cell disease

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN; POLYMERIZED HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE TEST; HEART RATE; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; SINGLE BLIND PROCEDURE;

ADULT; ANEMIA, SICKLE CELL; BLOOD SUBSTITUTES; EXERCISE TEST; HEART RATE; HEMOGLOBINS; HUMANS; MIDDLE AGED; SINGLE-BLIND METHOD;

EID: 0031156954     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Motulsky AG. Frequency of sickling disorders in US blacks. N Engl J Med 1973;288:31-3.
2. Vlahakes GJ, Lee R, Jacobs EE, LaRaia PJ, Austen WG. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990;100:379-88.
3. Hughes GS Jr, Francom SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, Jacobs EE. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 1995;126:444-51.
4. Hughes GS Jr, Antal EJ, Locker PK, Francom SF, Adams WJ, Jacobs EE. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1996;24:756-64.
5. Clark D. The influence of muscular fatigue patterns on the intercontraction rest interval. Med Sci Sports Exerc 1971;3:83-8.
6. Astrand PO, Rhyming A. Normogram for the calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J Appl Physiol 1954;7:218-21.
7. Van Camp S. Pharmacologic factors in exercise and exercise testing. In: Durstine L King AC, Painter PL, Roltman J, Zwiren LD, Kenney W, eds. Resource manual for guidelines for exercise testing and prescription. 2nd ed. Philadelphia: Lea & Felbiger Publishing Co. 1993:197-218.
8. Golding LA, Myers CR, Sinning WE. The YMCA's way to physical fitness: a guide book for instructors. National Board of YMCA, Chicago, 1982.
9. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-6.
10. Carache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, and the Investigators of the Multicenter Study of Hydoxyurea in Sickle Cell Anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
11. Griffin TC, McIntire D, Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994;330:733-7.
12. Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzombi M, Kaliula M. Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet1992;174:379-86.
13. Hughes GP, Yancey EP, Albrecht R, Locker PK, Francom SF, Orringer EP, Antal EJ, Jacobs EE. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharmacol Ther 1995;58: 434-43.
14. Abraham NG, Lavrovsky Y, Schwartzman RA, Stoltz RA, Lever RD, Gerritsen ME, Shibahara S, Kappas A. Transfection of the human heme-oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA 1995; 92: 6798-802.
15. Fowler NO, Smith O, Greenfield JC. Arterial blood oxygenation in sickle cell anemia. Am J Med Sci 1957;234:449-58.
16. Sproule BJ, Halden ER, Miller WF. A study of cardiopulmonary alterations in patients with sickle cell disease and its variants. J Clin Invest 1958;37:486-95.